These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11074907)

  • 81. Hepatopulmonary Syndrome.
    Lv Y; Fan D
    Dig Dis Sci; 2015 Jul; 60(7):1914-23. PubMed ID: 25732713
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Perioperative anesthesia management of extended partial liver resection. Pathophysiology of hepatic diseases and functional signs of hepatic failure].
    Herz S; Puhl G; Spies C; Jörres D; Neuhaus P; von Heymann C
    Anaesthesist; 2011 Feb; 60(2):103-17. PubMed ID: 21293838
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Methylene blue improves the hepatopulmonary syndrome.
    Schenk P; Madl C; Rezaie-Majd S; Lehr S; Müller C
    Ann Intern Med; 2000 Nov; 133(9):701-6. PubMed ID: 11074903
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.
    Jounieaux V; Leleu O; Mayeux I
    Intensive Care Med; 2001 Jun; 27(6):1103-4. PubMed ID: 11497151
    [No Abstract]   [Full Text] [Related]  

  • 85. Methylene blue improves the hepatopulmonary syndrome.
    Groneberg DA; Fischer A
    Ann Intern Med; 2001 Sep; 135(5):380-1. PubMed ID: 11529704
    [No Abstract]   [Full Text] [Related]  

  • 86. Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas.
    Fallon MB
    Ann Intern Med; 2000 Nov; 133(9):738-40. PubMed ID: 11074907
    [No Abstract]   [Full Text] [Related]  

  • 87. [Hepatopulmonary syndrome].
    Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
    Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
    Farina Junior JA; Celotto AC; da Silva MF; Evora PR
    Med Sci Monit; 2012 May; 18(5):HY13-7. PubMed ID: 22534716
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacological treatment for hepatopulmonary syndrome.
    Eshraghian A; Kamyab AA; Yoon SK
    Biomed Res Int; 2013; 2013():670139. PubMed ID: 24102057
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Methylene blue for refractory hypotension: a case report.
    Weissgerber AJ
    AANA J; 2008 Aug; 76(4):271-4. PubMed ID: 18777811
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target.
    Evora PR; Viaro F
    Curr Drug Targets; 2006 Sep; 7(9):1195-204. PubMed ID: 17017895
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Use of methylene blue to treat methemoglobinemia in infancy.
    Zenk KE
    Neonatal Netw; 2001 Aug; 20(5):62-8. PubMed ID: 12144224
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.